×

Obesity drug recalled due to cancer risk

The FDA is asking that Beliviq be withdrawn from the market immediately due to concern about an increased risk of a range of cancers.
Published: 9:27 AM MST February 18, 2020
Updated: 9:26 AM MST February 18, 2020